Thomas F. Jaki

Cambridge, ENG, GB 
Clinical Trials:Currently Recruiting for 1 Trial
Cambridge, ENG, GB 

Overview

Thomas Jaki practices in Cambridge, United Kingdom. His top areas of expertise are Severe Acute Respiratory Syndrome (SARS), Pneumonia, COVID-19, and Juvenile Idiopathic Arthritis (JIA).

His clinical research consists of co-authoring 187 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

Cambridge, ENG, United Kingdom
Other Locations
Lancaster, ENG, United Kingdom
Newcastle Upon Tyne, ENG NE24AX, United Kingdom
The School Of Life Course Sciences, Nottingham, ENG, United Kingdom
The School Of Life Course Sciences, Edinburgh, SCT, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Randomised Evaluation of COVID-19 Therapy
Randomised Evaluation of COVID-19 Therapy
Enrollment Status: Recruiting
Publish Date: January 05, 2024
Intervention Type: Drug, Biological
Study Drugs: Lopinavir, Ritonavir, Corticosteroid, Hydroxychloroquine, Azithromycin, Convalescent plasma, Tocilizumab, Immunoglobulin, Synthetic neutralising antibodies, Aspirin, Colchicine, Baricitinib, Anakinra, Dimethyl fumarate, Empagliflozin
Study Phase: Phase 3

187 Total Publications

Joint time-to-event partial order continual reassessment method and Joint time-to-event Bayesian logistic regression model: Statistical designs for dual agent phase I/II dose finding studies with late-onset toxicity and activity outcomes.
Joint time-to-event partial order continual reassessment method and Joint time-to-event Bayesian logistic regression model: Statistical designs for dual agent phase I/II dose finding studies with late-onset toxicity and activity outcomes.
Journal: Statistical methods in medical research
Published: December 05, 2025

Frequently Asked Questions about Thomas F. Jaki

Is Thomas F. Jaki a top-rated expert for Severe Acute Respiratory Syndrome (SARS)?

MediFind is an objective health platform that identifies experts based on real-world data. Thomas F. Jaki is classified as an Experienced expert for Severe Acute Respiratory Syndrome (SARS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Thomas F. Jaki participate in research or clinical trials?

Yes. Thomas F. Jaki has published 187 articles and abstracts on conditions like Severe Acute Respiratory Syndrome (SARS). You can view a list of Thomas F. Jaki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Jaki's expertise for a condition
ConditionClose
        View All 11 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile